School of Medicine

The Latest

Researchers to Test Novel Drug Combination Against Toughest Breast Cancers

Researchers at University of California San Diego School of Medicine have launched a phase Ib clinical trial to assess the safety and tolerability of cirmtuzumab, in combination with standard chemotherapy, to treat metastatic or locally advanced breast cancer that cannot be surgically removed.

Marijuana Found in Breast Milk up to Six Days after Use

To better understand how much marijuana or constituent compounds actually get into breast milk and how long it remains, researchers at University of California San Diego School of Medicine conducted a study, publishing online in Pediatrics.

Study Reveals How Enzyme Detects Ultraviolet Light Damage

In a paper published this week in the journal PNAS, researchers at University of California San Diego School of Medicine, with colleagues in Spain and Finland, describe for the first time how one type of RNA polymerase gets stalled by DNA lesions caused by exposure to ultraviolet (UV) light.

Christopher Kane, MD, Appointed CEO of UC San Diego Health Physicians

Christopher Kane, MD, has been appointed dean of clinical affairs for UC San Diego School of Medicine and CEO of UC San Diego Health Physicians, effective July 15. In these dual roles, Kane will collaborate with UC San Diego leadership to ensure that UC San Diego Health Physicians achieve the highest standards of service, access, quality, safety, and patient satisfaction and are integrated to support the unique and growing needs of an expanding academic health system and its growing regional network of providers.

Multi-Million-Dollar Grant to Grow Kidney Research

Researchers at University of California San Diego School of Medicine and the University of Alabama at Birmingham School of Medicine (UAB) have received renewed grant funding from the National Institute of Diabetes and Digestive and Kidney Diseases to expand research into the areas of acute kidney failure and acute kidney injuries.

HIV and a Tale of a Few Cities

In a pair of new modeling studies, researchers at University of California San Diego School of Medicine, with international colleagues, examined how policy reform in terms of drug decriminalization (in Mexico) and access to drug treatment (in Russia) might affect two regions hard hit by the HIV pandemic: Tijuana, Mexico and the Russian cities of Omsk and Ekaterinburg.